XERS — Xeris Biopharma Holdings Inc. price, chart and key statistics

Price data

Price

$11.13

YTD price return

+41.78%

YTD total return

+41.78%

Next earnings

Nov 5, 2026

Market cap

2B2018-09 366M2026-10 2B+454.5% over the window

Enterprise value

2.2B

Shares outstanding

182.3M2018-06 20.8M2026-06 182.3M+775.8% over the window

52W low

$5.25

52W high

$11.42

From 52W high

-2.54%

From 52W low

+112.00%

52W range

95%

Volume

Rel volume

0.93×

30D volume

3.1M

30D $ vol

29.6M

Fundamentals

Sales (ttm)

335.4M2017-12 16K2026-06 335.4M+2096237.5% over the window

Sales/share

$1.842017-12 $0.002026-06 $1.84+239259.6% over the window

EPS (ttm)

-$0.092021-03 -$1.312026-06 -$0.09-93.0% over the window

FCF (ttm)

27.5M2017-12 -25.4M2021-12 -96.6M+280.9% over the window

FCF/share

$0.152017-12 -$1.222021-12 -$0.77-36.5% over the window

Book value/share

-$0.052017-12 -$2.782026-06 -$0.05-98.1% over the window

Net margin

-5.12%2017-12 -165962.5%2026-06 -5.1%-100.0% over the window

ROA

-4.17%2017-12 -59.0%2026-06 -4.2%-92.9% over the window

Current ratio

1.452017-12 9.062026-06 1.45-84.0% over the window

Growth (CAGR, ttm) · 10Y

Sales

+36.36%2025-06-30 → 2026-06-30246M → 335.4M (+36.3% total)+33.15%2023-09-30 → 2026-06-30152.7M → 335.4M (+119.7% total)+58.59%2021-06-30 → 2026-06-3033.5M → 335.4M (+902.7% total)n/a

Shares

+12.91%2025-06-30 → 2026-06-30161.5M → 182.3M (+12.9% total)+10.63%2023-09-30 → 2026-06-30138.1M → 182.3M (+32.0% total)+22.35%2021-06-30 → 2026-06-3066.5M → 182.3M (+174.2% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share

+20.77%2025-06-30 → 2026-06-30$1.52 → $1.84 (+20.7% total)+20.36%2023-09-30 → 2026-06-30$1.11 → $1.84 (+66.4% total)+29.61%2021-06-30 → 2026-06-30$0.50 → $1.84 (+265.7% total)n/a

Price

+19.18%2025-10-20 → 2026-10-20$9.34 → $11.13 (+19.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+85.60%2023-10-20 → 2026-10-20$1.74 → $11.13 (+539.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+40.97%2021-10-20 → 2026-10-20$2.00 → $11.13 (+456.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

+19.18%2025-10-20 → 2026-10-20$9.34 → $11.13 (+19.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+85.60%2023-10-20 → 2026-10-20$1.74 → $11.13 (+539.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+40.97%2021-10-20 → 2026-10-20$2.00 → $11.13 (+456.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-120.5×2018-09 -13.782026-10 -118.22+757.8% over the window

Fwd P/E

29.0×

P/S (ttm)Market cap ÷ TTM revenue.

6.0×2018-09 22873.022026-10 6.05-100.0% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

-208.5×2018-09 3.352026-10 -208.47-6328.1% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

73.7×2018-09 -14.432026-10 -21.00+45.6% over the window

EV/EBITDA (fy)

57.9×

EV/Sales (ttm)

6.5×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

1.36%2018-12 -12.7%2021-12 -26.4%+108.3% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 182.3M ÷ 161.5M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-12.91%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-12.91%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($754.1M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-12.91%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2018-12 0.0%2026-06 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($2B). Same caveat as the cash buyback yield.

0.00%2018-12 0.0%2026-06 0.0%

Vs own 10Y history

P/S

58th

P/B

100th